846
Participants
Start Date
March 1, 2011
Primary Completion Date
April 1, 2012
Study Completion Date
April 24, 2012
GSK573719/GW642444 125/25
125/25 mcg once-daily
GSK573719/GW642444 62.5/25
62.5/26 mcg once-daily
GW642444
25 mcg once-daily
tiotropium bromide
18 mcg once-daily
GSK Investigational Site, México
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Potsdam
GSK Investigational Site, Pietra Ligure (SV)
GSK Investigational Site, Phoenixville
GSK Investigational Site, Milan
GSK Investigational Site, Vinnytsia
GSK Investigational Site, Tradate (VA)
GSK Investigational Site, Hamburg
GSK Investigational Site, Richmond
GSK Investigational Site, Newport News
GSK Investigational Site, Pavia
GSK Investigational Site, Gaffney
GSK Investigational Site, Greenville
GSK Investigational Site, Seneca
GSK Investigational Site, Rock Hill
GSK Investigational Site, Nîmes
GSK Investigational Site, Decatur
GSK Investigational Site, Hanover
GSK Investigational Site, Hanover
GSK Investigational Site, DeLand
GSK Investigational Site, Orlando
GSK Investigational Site, Pordenone
GSK Investigational Site, Tampa
GSK Investigational Site, Marburg
GSK Investigational Site, Birmingham
GSK Investigational Site, Nantes
GSK Investigational Site, Guadalajara
GSK Investigational Site, Dortmund
GSK Investigational Site, Dortmund
GSK Investigational Site, Zapopan
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Pisa
GSK Investigational Site, Rapid City
GSK Investigational Site, Kharkiv
GSK Investigational Site, Kharkiv
GSK Investigational Site, Clermont-Ferrand
GSK Investigational Site, Saint Charles
GSK Investigational Site, Zaporizhia
GSK Investigational Site, Stuttgart
GSK Investigational Site, Foggia
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Sinsheim
GSK Investigational Site, Ivano-Frankivsk
GSK Investigational Site, San Antonio
GSK Investigational Site, Munich
GSK Investigational Site, Donetsk
GSK Investigational Site, Avellino
GSK Investigational Site, Albuquerque
GSK Investigational Site, Nuremberg
GSK Investigational Site, Erlangen
GSK Investigational Site, San Diego
GSK Investigational Site, Simferopol
GSK Investigational Site, Catania
GSK Investigational Site, Bamberg
GSK Investigational Site, Saint-Pierre
GSK Investigational Site, Ploieşti
GSK Investigational Site, Moscow
GSK Investigational Site, Petrozavodsk
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Timișoara
GSK Investigational Site, Ryazan
GSK Investigational Site, Voronezh
GSK Investigational Site, Saratov
GSK Investigational Site, Saratov
GSK Investigational Site, Bacau
GSK Investigational Site, Tomsk
GSK Investigational Site, Irkutsk
GSK Investigational Site, Chita
GSK Investigational Site, Charleston
GSK Investigational Site, Rome
GSK Investigational Site, Mexico City
GSK Investigational Site, Lima
GSK Investigational Site, San Isidro
GSK Investigational Site, Jesus Maria
GSK Investigational Site, San Borja
GSK Investigational Site, San Miguel
GSK Investigational Site, Santiago de Surco
GSK Investigational Site, Callao
GSK Investigational Site, Lima
GSK Investigational Site, Gdansk
GSK Investigational Site, Gidle
GSK Investigational Site, Krakow
GSK Investigational Site, Lubliniec
GSK Investigational Site, Sopot
GSK Investigational Site, Włocławek
GSK Investigational Site, Zabrze
GSK Investigational Site, Bucharest
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Kiev
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY